Webinars (38)
Q&A clinic on Substance, Organisation, Referentials Management Services - September 2026
The EMA's regulatory data management services team is available in this Q&A session to answer your questions regarding the Substance, Organisation, Referentials Management Services.
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - September 2026
In this Q&A session, EMA's regulatory data management services team is available to answer your questions regarding the XEVMPD Service.
Nature finance - Science for policy
The workshop is structured to facilitate cross-fertilisation between science and policy.
18th Industry Standing Group (ISG) meeting
ISG aims to facilitate regular exchange of views and promote dialogue on new and upcoming legislatio
Workshop on advancing proof-of-concept data in paediatric oncology drug development
This initiative is part of the Consolidated 3-year rolling workplan of the non-clinical domain for 2026-2028.
Joint European Commission (EC) / European Medicines Agency (EMA) multi-stakeholder workshop on regulatory sandbox
A regulatory sandbox establishes a time-limited framework in which developers can design, validate, and test innovative medicines or methodologies in a controlled, real-world environment, under strict regulatory oversight.
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - September 2026
The training focuses on: explaining the guidance and specifically the mandatory data elements necess
PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – September 2026
The PMS team will be available in this Q&A session to answer your questions regarding the Product Management Service (PMS) User Interface (PUI) and the Application Programming Interface (API), through which both human centrally authorised products (C...
Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) multistakeholder workshop on real-world data collection in duchenne muscular dystrophy
This joint HMA/EMA hybrid workshop is anchored in the Network Data Steering Group workplan and follows on stakeholders’ interactions to support medicines regulation and access in the field of Duchenne Muscular Dystrophy (DMD).
Regulatory Perspectives on Herbal Medicinal / Botanical Drug Product Development: Joint FDA / EMA Workshop
Public interest in the therapeutic potential of herbal medicinal / botanical drug products continues to grow, driving increased efforts to develop such products as regulated medicinal products.
Root cause analysis and event investigation training
An annual training course on the investigation and analysis of unusual events at nuclear installations.
Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - October 2026
EudraVigilance (EV) is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA).
SPOR and XEVMPD status update webinar - Q4 2026
This is a public webinar on Substance, Product, Organisation, Referentials (SPOR) and XEVMPD services status update.
Q&A clinic on Substance, Organisation, Referentials Management Services - October 2026
The EMA's regulatory data management services team is available in this Q&A session to answer your questions regarding the Substance, Organisation, Referentials Management Services.
PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – October 2026
The PMS team will be available in this Q&A session to answer your questions regarding the Product Management Service (PMS) User Interface (PUI) and the Application Programming Interface (API), through which both human centrally authorised products (C...
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - October 2026
In this Q&A session, EMA's regulatory data management services team is available to answer your questions regarding the XEVMPD Service.
The JRC at the European Week of Regions and Cities 2026
The Joint Research Centre is once again taking part in the European Week of Regions and Cities (EWRC), with experts contributing to discussions on regional competitiveness, demographic change and water resilience, among other topics.
Clinical Trials Information System (CTIS) sponsor end user training programme - October 2026
European Medicines Agency (EMA) offers a virtual training programme, organised by DIA, to support sponsor user preparedness concerning the new way of submitting Clinical Trial Applications (CTA) in the EEA via the new Clinical Trial Information Syst...
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - October 2026
The Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) was established under Regulation 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and me...
37th DAAAM International Symposium, 2026
Welcome to the 37th DAAAM International Symposium – Virtual Online Edition, hosted by Vienna University of Technology, Vienna, Austria, EU and organized under auspices of Danube Rectors´ Conference
SME info day - navigating EMA support: From development to market authorisation
The European Medicines Agency (EMA) is organising a hybrid SME Info Day.
Q&A clinic on Substance, Organisation, Referentials Management Services - November 2026
The EMA's regulatory data management services team is available in this Q&A session to answer your questions regarding the Substance, Organisation, Referentials Management Services.
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - November 2026
In this Q&A session, EMA's regulatory data management services team is available to answer your questions regarding the XEVMPD Service.
HMA/EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations
The European Medicines Regulatory Network is strengthening its use of data and AI, to support innovation, enable more efficient regulatory processes, and reach better decisions for public and animal health.
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - November 2026
The training focuses on: explaining the guidance and specifically the mandatory data elements necess
Competence Centre on Composite Indicators and Scoreboards (CC-COIN) 10-year anniversary
The JRC's Competence Centre on Composite Indicators and Scoreboards celebrates 10 years of continuous policy support and institutional impact.
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 2026
The Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) was established under Regulation 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and me...
Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - November 2026
EudraVigilance (EV) is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA).
PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – November 2026
The PMS team will be available in this Q&A session to answer your questions regarding the Product Management Service (PMS) User Interface (PUI) and the Application Programming Interface (API), through which both human centrally authorised products (C...
Second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection
Heads of Medicines Agencies (HMA) and European Medicines Agency (EMA) are hosting the second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection on Tuesday, 1st December 2026.
Q&A clinic on Substance, Organisation, Referentials Management Services - December 2026
The EMA's regulatory data management services team is available in this Q&A session to answer your questions regarding the Substance, Organisation, Referentials Management Services.
PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – December 2026
The PMS team will be available in this Q&A session to answer your questions regarding the Product Management Service (PMS) User Interface (PUI) and the Application Programming Interface (API), through which both human centrally authorised products (C...
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - December 2026
In this Q&A session, EMA's regulatory data management services team is available to answer your questions regarding the XEVMPD Service.